会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 30. 发明申请
    • STREPTOCOCCUS PNEUMONIAE PILUS ANTIGENS
    • STREPTOCOCCUS PNEUMONIAE PILUS抗原
    • WO2008146164A2
    • 2008-12-04
    • PCT/IB2008002108
    • 2008-05-23
    • NOVARTIS AGDONATI CLAUDIOMASIGNANI VEGAMORA MARIROSAMOSCHIONI MONICA
    • DONATI CLAUDIOMASIGNANI VEGAMORA MARIROSAMOSCHIONI MONICA
    • C07K14/315A61K39/09C07K16/12C12N9/10C12N9/52
    • C07K14/3156A61K39/00A61K2039/505A61K2039/53C12N9/52G01N33/56944G01N2333/315G01N2469/10
    • Polypeptides from Streptococcus pneumoniae are described. In some aspects the polypeptides include pili polypeptides from a second pili island (pilus II island (INVl 04B)) identified in Streptococcus pneumoniae isolate INVl 04. In other aspects the polypeptides include pili polypeptides and non-pilus polypeptides from Streptococcus pneumoniae strains 23F, INV200, and OXC141 that are absent from Streptococcus pneumoniae isolate INV104. The polypeptides, including fragments and variants thereof, may be used in immunogenic compositions for prophylactic or therapeutic immunization against Streptococcus pneumoniae. The polypeptides are also disclosed to be used in compositions useful for the production of antibodies and immunostimulants. Also presented are methods of inhibiting Streptococcus pneumoniae, methods of treating Streptococcus pneumoniae infection, methods of identifying inhibitors of Streptococcus pneumoniae and methods for diagnosing/detecting Streptococcus pneumoniae infection.
    • 描述了来自肺炎链球菌的多肽。 在一些方面,多肽包括来自肺炎链球菌分离株INV04中鉴定的第二个皮岛(pilus II岛(INVl 04B))的多肽。在其它方面,多肽包括来自肺炎链球菌菌株23F,INV200的多肽和非菌毛多肽 ,和OXC141,其不存在于肺炎链球菌分离株INV104中。 多肽,包括其片段和变体,可用于免疫原性组合物,用于针对肺炎链球菌的预防性或治疗性免疫。 还公开了将多肽用于可用于产生抗体和免疫兴奋剂的组合物中。 还提出了抑制肺炎链球菌的方法,肺炎链球菌感染的治疗方法,肺炎链球菌抑制剂的鉴定方法和肺炎链球菌感染诊断方法。